Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.52 [1.44-1.6],9.50683061217732e-59,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,2.79 [2.13-3.65],9.99074971293434e-14,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LPA,Apolipoprotein(a),Inverse variance weighted,38,1.11 [1.08-1.15],5.13407890772353e-12,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOE,Apolipoprotein E,Inverse variance weighted,23,0.84 [0.78-0.91],4.54144467806471e-06,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CPE,Carboxypeptidase E,Inverse variance weighted,11,0.91 [0.86-0.95],0.000116643767809149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AGRN,Agrin,Inverse variance weighted,17,0.9 [0.85-0.96],0.000413338061251712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.2 [1.08-1.33],0.00105521923270986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,16,0.9 [0.84-0.96],0.0011621394302185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.84 [0.75-0.93],0.00148071259494264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,22,0.95 [0.91-0.98],0.00237909955650925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.81 [0.71-0.93],0.00314347494726302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,0.85 [0.76-0.95],0.00345532427726213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.9 [0.84-0.97],0.00346479161364942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.88 [0.81-0.96],0.00496415513063057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.3 [1.08-1.57],0.00525598461705253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD83,CD83 antigen,Inverse variance weighted,5,1.14 [1.04-1.25],0.00556395233164983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.82 [0.71-0.94],0.00575279185271208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.1 [1.03-1.18],0.00592428171311248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MFGE8,Lactadherin,Inverse variance weighted,11,1.08 [1.02-1.15],0.00618744970705336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.79 [0.66-0.94],0.00663997392368468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.25 [1.06-1.46],0.00751111769979048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.27 [1.06-1.52],0.00806544249945414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,0.93 [0.88-0.98],0.00834879616727971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,XCL1,Lymphotactin,Inverse variance weighted,31,0.96 [0.93-0.99],0.00841447069774111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.19 [1.04-1.36],0.00975294288622841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.94 [0.89-0.99],0.0134360349008362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NTF3,Neurotrophin-3,Inverse variance weighted,8,0.88 [0.79-0.97],0.0135074003293621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.19 [1.04-1.37],0.0140133078967106,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,1.1 [1.02-1.18],0.0145365306897363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MPO,Myeloperoxidase,Inverse variance weighted,11,1.07 [1.01-1.14],0.0182045263866064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.92 [0.86-0.99],0.0187623405795112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,12,1.09 [1.01-1.18],0.0189466415011711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.89 [0.81-0.98],0.0196890875246601,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.89 [0.81-0.98],0.0200600644769793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.96 [0.94-0.99],0.0206159211323804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.81 [0.68-0.97],0.0212013689673404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.09 [1.01-1.17],0.0228379631218534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1.05 [1.01-1.1],0.0231642668060836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.9 [0.83-0.99],0.0240276352503515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.09 [1.01-1.17],0.0245295374941078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.08 [1.01-1.16],0.0246793537234693,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.03 [1-1.06],0.0253412681253499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHGA,Chromogranin-A,Inverse variance weighted,3,1.11 [1.01-1.22],0.0260561418342241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.95 [0.9-0.99],0.0270286563062329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.14 [1.01-1.27],0.0281886208942429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL19,Interleukin-19,Inverse variance weighted,11,1.06 [1.01-1.12],0.030197755091296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.95 [0.91-1],0.0303526106485163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.94 [0.88-0.99],0.0308536610584874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.6 [1.04-2.47],0.0323617930441447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.97 [0.95-1],0.0324453638151786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,1.35 [1.03-1.78],0.0326728653371885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.96 [0.93-1],0.0344124263493949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,32,1.04 [1-1.07],0.035799332667622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.95 [0.91-1],0.0368514643413446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.03 [1-1.06],0.0380544210141426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.06 [1-1.12],0.0389153466331985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOD,Apolipoprotein D,Inverse variance weighted,7,1.06 [1-1.13],0.042339434834756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.89 [0.8-1],0.042468436999815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.05 [1-1.09],0.042704253542318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.14 [1-1.29],0.0475719480795311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.13 [1-1.27],0.0477607674438028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.07 [1-1.14],0.0510728533310093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.94 [0.88-1],0.0542521009463217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANXA10,Annexin A10,Wald ratio,1,1.43 [0.99-2.06],0.0558131683351426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,0.9 [0.8-1],0.0559284082709087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FURIN,Furin,Wald ratio,1,1.11 [1-1.24],0.0582647661623352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.07 [1-1.14],0.0595769272024339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1.02 [1-1.05],0.0597070182461733,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.51 [0.98-2.33],0.0599003891159894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACAN,Aggrecan core protein,Inverse variance weighted,3,0.82 [0.67-1.01],0.0607537246850898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MSLN,Mesothelin,Inverse variance weighted,25,1.03 [1-1.06],0.0631824051025206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.98 [0.95-1],0.0647372101760522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.09 [0.99-1.2],0.0650603808527699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ELN,Elastin,Inverse variance weighted,2,1.33 [0.98-1.8],0.0716840519022505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.15 [0.99-1.35],0.0742251065589237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LCAT,Phosphatidylcholine-sterol acyltransferase,Wald ratio,1,1.17 [0.98-1.39],0.0755203147655919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.04 [1-1.09],0.0760268626712341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.13 [0.99-1.3],0.0780601791233574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.94 [0.87-1.01],0.0785611744780829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.02 [1-1.04],0.0788324533374425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.96 [0.91-1.01],0.0788649481324978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FBLN2,Fibulin-2,Inverse variance weighted,11,1.05 [0.99-1.11],0.0804327437234764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.97 [0.94-1],0.0811762072902218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.97 [0.94-1],0.0817642752181852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.22 [0.97-1.52],0.0823580618453208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.03 [1-1.06],0.0826232855851294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.25 [0.97-1.62],0.0829457405039363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCG2,Secretogranin-2,Wald ratio,1,1.41 [0.95-2.1],0.0855448836794134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.02 [1-1.05],0.0860705417968451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.09 [0.99-1.19],0.087604859831845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PVR,Poliovirus receptor,Inverse variance weighted,27,1.03 [0.99-1.08],0.0892041579299221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NRP2,Neuropilin-2,Inverse variance weighted,11,0.95 [0.89-1.01],0.0980938667221659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCN5,CCN family member 5,Inverse variance weighted,8,1.13 [0.98-1.31],0.104238156106895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OCLN,Occludin,Inverse variance weighted,2,1.13 [0.98-1.3],0.105090108422917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.02 [0.99-1.06],0.106188646165609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.95 [0.9-1.01],0.109661304704147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,10,0.95 [0.9-1.01],0.111715919350708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,0.98 [0.96-1],0.112044516763532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.06 [0.99-1.13],0.12034402869883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,39,0.97 [0.93-1.01],0.121635201568559,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.04 [0.99-1.09],0.124292455320612,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.8 [0.6-1.07],0.126313732160911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,0.99 [0.97-1],0.128566108008841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.03 [0.99-1.06],0.129492852983673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.06 [0.98-1.14],0.1316980372521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.03 [0.99-1.08],0.132483170758706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PENK,Proenkephalin-A,Inverse variance weighted,19,1.04 [0.99-1.09],0.132500745421202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,1.16 [0.96-1.4],0.132700074192836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [0.99-1.06],0.133061321660662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.02 [0.99-1.05],0.133661549723715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.04 [0.99-1.09],0.133696409478991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.07 [0.98-1.16],0.13542073309077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.96 [0.9-1.01],0.138245412178347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.98 [0.95-1.01],0.143435980314235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TMPRSS15,Enteropeptidase,Inverse variance weighted,3,1.11 [0.96-1.27],0.147374856146802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANG,Angiogenin,Inverse variance weighted,19,1.03 [0.99-1.07],0.149084016861266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,0.97 [0.93-1.01],0.149907002672622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD27,CD27 antigen,Inverse variance weighted,9,0.96 [0.91-1.01],0.150425733708909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.03 [0.99-1.06],0.154015412312191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,7,1.14 [0.95-1.38],0.154301404082635,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.85 [0.69-1.06],0.155128450899694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.05 [0.98-1.11],0.157122311510896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCN4,CCN family member 4,Inverse variance weighted,27,1.03 [0.99-1.07],0.157777065379147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,0.95 [0.89-1.02],0.158140224572642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,0.98 [0.96-1.01],0.159598445327725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSF,Cathepsin F,Inverse variance weighted,10,1.05 [0.98-1.13],0.160646030186177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL17C,Interleukin-17C,Inverse variance weighted,3,1.1 [0.96-1.27],0.162327830941678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.05 [0.98-1.11],0.166856036826987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.09 [0.96-1.24],0.170426087448629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.87 [0.7-1.06],0.171070422126225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.92 [0.83-1.03],0.171833198122572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,0.93 [0.84-1.03],0.17261881796758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.98 [0.95-1.01],0.183350405613599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.17 [0.93-1.47],0.189250407175149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.04 [0.98-1.12],0.192207586146818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.98 [0.95-1.01],0.197955577260313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1.03 [0.99-1.07],0.198514159627692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.96 [0.89-1.02],0.198555366501579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LDLR,Low-density lipoprotein receptor,Wald ratio,1,1.67 [0.76-3.65],0.198804042466296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.15 [0.93-1.41],0.199307356749586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.13 [0.94-1.36],0.205704359037099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.89 [0.73-1.07],0.206257342690088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.98 [0.95-1.01],0.206905847810583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.03 [0.98-1.09],0.206970595636684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.96 [0.91-1.02],0.207860239056242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.21 [0.9-1.61],0.209246799200353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.05 [0.98-1.12],0.210590571901057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.18 [0.91-1.53],0.21497923618873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTN,Pleiotrophin,Inverse variance weighted,4,0.9 [0.76-1.07],0.215587114634378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.05 [0.97-1.15],0.219225884054018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.03 [0.98-1.08],0.221485177035033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.09 [0.95-1.24],0.221705792547803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.79 [0.55-1.15],0.226193462456042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PGF,Placenta growth factor,Inverse variance weighted,2,0.59 [0.25-1.39],0.227121886180616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.02 [0.99-1.06],0.229483122511981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BCAN,Brevican core protein,Inverse variance weighted,3,1.05 [0.97-1.13],0.234675723394945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.13 [0.92-1.38],0.235013542120866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.93 [0.82-1.05],0.235661947949556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.95 [0.88-1.03],0.247104629611334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.08 [0.94-1.25],0.251967089429991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.22 [0.87-1.73],0.252737579759784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.05 [0.97-1.13],0.254537450269084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.04 [0.97-1.12],0.255740113352778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,1.04 [0.97-1.1],0.258093474544446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.94 [0.83-1.05],0.260254454002386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.98 [0.94-1.02],0.260352794850447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SDC1,Syndecan-1,Inverse variance weighted,2,0.89 [0.72-1.09],0.260939008776752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.08 [0.95-1.22],0.262860251678396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.04 [0.97-1.12],0.263171700544003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EDN1,Endothelin-1,Inverse variance weighted,3,1.07 [0.95-1.22],0.268875102101257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.31 [0.81-2.14],0.274160735754219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CREG1,Protein CREG1,Inverse variance weighted,3,0.94 [0.85-1.05],0.275285187423215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.23 [0.85-1.8],0.276782168740154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.05 [0.96-1.14],0.277854223921871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.97 [0.93-1.02],0.279104101572538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.05 [0.96-1.15],0.279252239778164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCN3,CCN family member 3,Inverse variance weighted,19,1.03 [0.98-1.09],0.281279591253244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.05 [0.96-1.15],0.281929277891924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,43,0.98 [0.95-1.02],0.283331096121641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,0.92 [0.8-1.07],0.283676247123699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.08 [0.94-1.23],0.285390409938805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.1 [0.92-1.31],0.294036939286583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.09 [0.93-1.29],0.301406185174599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLB,Beta-klotho,Inverse variance weighted,32,1.02 [0.99-1.05],0.303220351171455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.96 [0.9-1.04],0.307214343902416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.98 [0.94-1.02],0.307328026601414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.97 [0.93-1.02],0.307366867909007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,C7,Complement component C7,Inverse variance weighted,38,0.99 [0.96-1.01],0.309464824424431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LMNB2,Lamin-B2,Wald ratio,1,1.26 [0.8-1.99],0.314419526303338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,1.08 [0.93-1.24],0.31489285154059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.93 [0.81-1.07],0.318738585496219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.06 [0.95-1.17],0.32030494090328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.92 [0.77-1.09],0.321867084262042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.99-1.04],0.323189735873529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.03 [0.97-1.1],0.325696080684369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.82 [0.55-1.22],0.326623206586381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.94 [0.82-1.07],0.328455454691356,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.77 [0.46-1.3],0.32877457210435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.03 [0.97-1.1],0.328943107260839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CNTN5,Contactin-5,Inverse variance weighted,28,1.02 [0.98-1.05],0.33338415652723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.03 [0.97-1.1],0.334303707466928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLAT,Tissue-type plasminogen activator,Wald ratio,1,0.84 [0.58-1.2],0.334510089456607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC3B,Tetranectin,Inverse variance weighted,7,0.96 [0.89-1.04],0.34205159367234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1.08 [0.93-1.25],0.343218758406648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,11,1.04 [0.96-1.11],0.344884702919292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,3,1.22 [0.81-1.85],0.345907207818503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.04 [0.96-1.11],0.348571743033522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.91 [0.74-1.12],0.350896204077706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OSM,Oncostatin-M,Wald ratio,1,1.14 [0.87-1.49],0.354484476873312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.04 [0.96-1.12],0.356545214379174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.89 [0.69-1.14],0.356755464012409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.11 [0.89-1.38],0.358056963151118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL10,Interleukin-10,Wald ratio,1,0.92 [0.77-1.1],0.364481596693822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.98 [0.93-1.03],0.365194925128922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.02 [0.97-1.08],0.365641582131909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PRSS8,Prostasin,Inverse variance weighted,5,0.94 [0.83-1.07],0.367692371563622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.04 [0.96-1.13],0.36947804009069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.96 [0.88-1.05],0.372395836720565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.08 [0.91-1.28],0.375102145060282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPON1,Spondin-1,Inverse variance weighted,21,0.98 [0.92-1.03],0.376797195385501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.02 [0.98-1.06],0.377342574520176,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.87 [0.64-1.18],0.379283806960104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.95-1.02],0.379480739893789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PGA4,Pepsin A-4,Inverse variance weighted,2,1.12 [0.87-1.43],0.3800343645341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.94 [0.81-1.08],0.383944211093739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MB,Myoglobin,Wald ratio,1,1.25 [0.76-2.05],0.384535075598185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PYY,Peptide YY,Inverse variance weighted,6,1.04 [0.95-1.15],0.387863464033022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.03 [0.97-1.09],0.389714881361442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.02 [0.97-1.08],0.397013384104748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP10,Stromelysin-2,Inverse variance weighted,22,0.98 [0.94-1.03],0.401265432843351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.06 [0.92-1.22],0.401922376903249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,0.98 [0.93-1.03],0.403197633059962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.97 [0.89-1.05],0.407197984643717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.94 [0.82-1.09],0.407425663844742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPP1,Osteopontin,Inverse variance weighted,8,0.94 [0.81-1.09],0.408243732277675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MUC13,Mucin-13,Inverse variance weighted,9,0.97 [0.9-1.04],0.408608749516279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.95 [0.84-1.08],0.409263926661354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.97 [0.91-1.04],0.410465215005055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.98 [0.94-1.03],0.414639409034563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.98 [0.92-1.03],0.416624173993691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1.01 [0.98-1.04],0.419492945341921,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.98-1.04],0.420109060350806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.01 [0.98-1.04],0.424291386197121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,1.11 [0.85-1.45],0.42482515051035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.97 [0.9-1.04],0.424938087463512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.93 [0.78-1.11],0.425057543424993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VWC2,Brorin,Inverse variance weighted,22,1.02 [0.97-1.07],0.42523793127055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,0.98 [0.94-1.03],0.42783531961435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.08 [0.89-1.3],0.43507574690476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.04 [0.94-1.14],0.435694993547962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.9 [0.7-1.17],0.438505934680123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.07 [0.91-1.25],0.442650368395289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TCOF1,Treacle protein,Wald ratio,1,0.87 [0.6-1.25],0.446354487083672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS4,Galectin-4,Inverse variance weighted,4,0.92 [0.75-1.13],0.44643176463867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.02 [0.97-1.06],0.446765143547777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHGB,Secretogranin-1,Inverse variance weighted,27,0.99 [0.95-1.02],0.447585127969286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PALM,Paralemmin-1,Inverse variance weighted,6,1.04 [0.94-1.14],0.449454616515828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.97 [0.9-1.05],0.451821108895698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.02 [0.97-1.06],0.452529436667658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BCHE,Cholinesterase,Inverse variance weighted,30,1.02 [0.97-1.06],0.457731331018184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.07 [0.9-1.27],0.464892645185162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.98 [0.93-1.03],0.465258446604826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.98 [0.92-1.04],0.472466532771403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,0.98 [0.93-1.04],0.475429963034771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TF,Serotransferrin,Inverse variance weighted,11,0.98 [0.93-1.04],0.48084584134411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1.03 [0.96-1.1],0.481423689989958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.21 [0.7-2.09],0.486721304919137,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NECTIN4,Nectin-4,Inverse variance weighted,7,1.02 [0.96-1.08],0.49050198190299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.99 [0.95-1.02],0.492261248311594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.02 [0.97-1.07],0.495877946875656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SELL,L-selectin,Inverse variance weighted,18,0.99 [0.95-1.03],0.496161282068162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.04 [0.92-1.18],0.499859141725339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.02 [0.95-1.1],0.502641682018401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.98 [0.92-1.04],0.502848166308173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITGA5,Integrin alpha-5,Wald ratio,1,0.9 [0.65-1.23],0.506755035836367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.98 [0.92-1.04],0.507538926738332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPON2,Spondin-2,Inverse variance weighted,4,0.97 [0.9-1.05],0.507549322071291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.98 [0.92-1.04],0.511813427743045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1.02 [0.96-1.08],0.511834090351812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.98 [0.91-1.05],0.513971627903632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.97 [0.89-1.06],0.517858430051293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.99 [0.95-1.03],0.519208561721686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.97 [0.88-1.07],0.519690529925775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,12,1.01 [0.97-1.05],0.522395881740282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1.01 [0.98-1.05],0.522960528061419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AREG,Amphiregulin,Inverse variance weighted,3,0.94 [0.77-1.14],0.523636839323591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.86 [0.54-1.37],0.523944135316293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MENT,Protein MENT,Inverse variance weighted,3,0.98 [0.93-1.04],0.52510805719112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1.01 [0.97-1.06],0.527261473108318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADA,Adenosine deaminase,Inverse variance weighted,22,0.99 [0.96-1.02],0.530128098967515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSL,Cathepsin L1,Wald ratio,1,1.14 [0.76-1.71],0.532574217049322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAYN,Layilin,Inverse variance weighted,20,1.02 [0.96-1.07],0.533477028326901,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.93 [0.74-1.17],0.534048715909895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.98 [0.91-1.05],0.534874472354192,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,0.96 [0.84-1.09],0.53514098049145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSB,Cathepsin B,Inverse variance weighted,26,0.99 [0.96-1.02],0.537104908998621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.01 [0.98-1.03],0.537769482523602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NRP1,Neuropilin-1,Inverse variance weighted,12,0.98 [0.93-1.04],0.537869175311668,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.96 [0.85-1.09],0.542639171872391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.03 [0.94-1.12],0.543171398174751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GRN,Progranulin,Inverse variance weighted,7,0.98 [0.92-1.05],0.543368420743617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,32,1.01 [0.98-1.04],0.543400716006748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSD,Cathepsin D,Inverse variance weighted,17,1.02 [0.96-1.07],0.54574552688531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLG,Plasminogen,Inverse variance weighted,20,1.03 [0.94-1.13],0.548952710883476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,20,1.01 [0.97-1.06],0.55115430566994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,18,1.02 [0.96-1.08],0.551830448198271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.98 [0.93-1.04],0.553529245533603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FUOM,Fucose mutarotase,Inverse variance weighted,3,1.06 [0.88-1.28],0.555153962717933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,23,1.01 [0.97-1.05],0.55646627922393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.03 [0.92-1.16],0.558641873068365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,0.97 [0.87-1.08],0.558688036389266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.01 [0.98-1.04],0.559461722907477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.01 [0.97-1.07],0.56275707005598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HEPACAM2,HEPACAM family member 2,Wald ratio,1,1.34 [0.5-3.57],0.563001881819043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.04 [0.91-1.19],0.56600359244779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.87 [0.55-1.38],0.566035928458819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.01 [0.97-1.05],0.566178058663056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PKD1,Polycystin-1,Inverse variance weighted,12,1.02 [0.95-1.09],0.568254693652711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CFD,Complement factor D,Inverse variance weighted,11,1.02 [0.96-1.08],0.568914246795617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSO,Cathepsin O,Inverse variance weighted,6,0.97 [0.89-1.07],0.571908521978963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.04 [0.9-1.2],0.572150283522818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.97 [0.89-1.07],0.572628614571355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.06 [0.86-1.31],0.572984195308535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.8 [0.37-1.74],0.573155852658806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.94 [0.77-1.16],0.573785081135093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HJV,Hemojuvelin,Wald ratio,1,1.03 [0.93-1.14],0.574928684921459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.06 [0.86-1.3],0.575090792516364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP6,Gastrotropin,Wald ratio,1,0.96 [0.83-1.11],0.579426254618397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.03 [0.92-1.16],0.582854511098698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.01 [0.97-1.05],0.584601345876756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.97 [0.86-1.09],0.585720302936635,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CALB1,Calbindin,Inverse variance weighted,2,0.94 [0.75-1.17],0.591161372980122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DPT,Dermatopontin,Inverse variance weighted,21,1.01 [0.97-1.06],0.596630678858271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.04 [0.89-1.23],0.600241414563794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.99 [0.94-1.04],0.600422385088709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.01 [0.97-1.05],0.607605776460743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.01 [0.97-1.05],0.614110977671863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EGFLAM,Pikachurin,Inverse variance weighted,19,1.01 [0.98-1.04],0.615206400165611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,UMOD,Uromodulin,Inverse variance weighted,29,0.99 [0.97-1.02],0.617424917943552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REN,Renin,Inverse variance weighted,4,1.02 [0.93-1.12],0.623893633555526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.07 [0.81-1.42],0.624411562812831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.04 [0.88-1.23],0.629977518633244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.09 [0.77-1.53],0.634838068979589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.02 [0.95-1.09],0.6354541132337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,0.99 [0.96-1.03],0.637619779191282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNN,Tenascin-N,Inverse variance weighted,44,0.99 [0.97-1.02],0.637655442490371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.97 [0.86-1.1],0.638550465394994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.03 [0.9-1.19],0.642819566926316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.02 [0.93-1.13],0.643593066960404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.02 [0.94-1.1],0.646533728124917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.99 [0.94-1.04],0.651238626395021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.96 [0.79-1.16],0.65272655386723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,0.99 [0.93-1.05],0.656518476870305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.01 [0.98-1.04],0.659074787990102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MME,Neprilysin,Inverse variance weighted,3,0.9 [0.57-1.44],0.663734040625637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,0.95 [0.77-1.18],0.664706060208931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.99 [0.94-1.04],0.665351000485077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AMBP,Protein AMBP,Inverse variance weighted,3,1.03 [0.9-1.18],0.666319292153758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CFI,Complement factor I,Inverse variance weighted,6,0.98 [0.89-1.07],0.668436781979781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.97 [0.86-1.1],0.675274128282528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.98 [0.88-1.08],0.676873943596341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OGN,Mimecan,Inverse variance weighted,30,1.01 [0.97-1.05],0.677049451034788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.99 [0.95-1.03],0.67750612227966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COLEC12,Collectin-12,Inverse variance weighted,11,0.98 [0.91-1.06],0.677520120496167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.01 [0.95-1.08],0.677611473302826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.04 [0.88-1.23],0.677716769501454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EZR,Ezrin,Wald ratio,1,0.93 [0.66-1.31],0.679056952995164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.1 [0.71-1.7],0.680986592111222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.98-1.03],0.681461127041745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,21,1.01 [0.96-1.06],0.68194351212643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,1.04 [0.85-1.29],0.683224889017089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.93 [0.67-1.3],0.684331726823189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.98 [0.9-1.07],0.686702431537174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NFASC,Neurofascin,Inverse variance weighted,15,1.01 [0.96-1.06],0.686807357160002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.06 [0.79-1.42],0.69171743616078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.03 [0.88-1.21],0.694675467095233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPO,Erythropoietin,Inverse variance weighted,5,1.04 [0.84-1.3],0.696362325987363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADIPOQ,Adiponectin,Inverse variance weighted,13,1.01 [0.95-1.08],0.698104160593498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.99 [0.96-1.03],0.698388688134547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.01 [0.97-1.04],0.698841504187777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.99 [0.94-1.04],0.699470074967581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.99 [0.94-1.04],0.702151105863081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.08 [0.74-1.57],0.703044909748382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.99 [0.93-1.05],0.704540689985658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CALB2,Calretinin,Wald ratio,1,0.94 [0.7-1.28],0.706895554278564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.02 [0.93-1.11],0.707720626740162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.93 [0.62-1.39],0.712325339101334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.94 [0.66-1.33],0.722444520738201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.99 [0.93-1.05],0.723587546597138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.97 [0.81-1.16],0.730922674346063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RSPO3,R-spondin-3,Inverse variance weighted,6,0.98 [0.89-1.08],0.733075433380701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.02 [0.91-1.14],0.734281923327094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CDH2,Cadherin-2,Inverse variance weighted,3,0.96 [0.74-1.24],0.738556224883089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.98 [0.86-1.11],0.740134082156638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.96 [0.73-1.25],0.740553306416587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.97-1.04],0.743124150559117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLK4,Kallikrein-4,Inverse variance weighted,17,0.99 [0.95-1.04],0.743508252853883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.99 [0.93-1.05],0.743642355529172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.02 [0.92-1.12],0.74523430994744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.02 [0.9-1.15],0.746673903527983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.03 [0.88-1.2],0.748850528621181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPPC,C-type natriuretic peptide,Wald ratio,1,0.93 [0.59-1.46],0.749641557246273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.99 [0.91-1.07],0.752269713615677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,0.99 [0.95-1.04],0.753694195662755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.99 [0.94-1.05],0.754102514144968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RTBDN,Retbindin,Inverse variance weighted,3,1.02 [0.9-1.15],0.754135220334913,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.99 [0.91-1.07],0.754724240649518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.92 [0.56-1.52],0.75519356428669,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CST3,Cystatin-C,Inverse variance weighted,10,1.01 [0.95-1.07],0.755588610631361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACY1,Aminoacylase-1,Inverse variance weighted,4,0.97 [0.81-1.17],0.7565211107101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.05 [0.76-1.45],0.757651479556367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.01 [0.97-1.04],0.760747811720045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.01 [0.95-1.07],0.760921787238502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SERPINB8,Serpin B8,Inverse variance weighted,28,1 [0.98-1.02],0.762491270931009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.04 [0.77-1.42],0.777556002842457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1 [0.97-1.04],0.778362607789688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1 [0.98-1.02],0.780059446351312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PSAP,Prosaposin,Inverse variance weighted,5,1.02 [0.91-1.14],0.780302104884815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.02 [0.9-1.15],0.782376546695903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.04 [0.76-1.43],0.783398984768066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,1.04 [0.77-1.41],0.78776935514945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP7,Matrilysin,Inverse variance weighted,13,0.99 [0.93-1.05],0.788491652988935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.01 [0.92-1.12],0.789060142155768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,0.98 [0.86-1.12],0.792222643168013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CALCA,Calcitonin,Inverse variance weighted,5,1.04 [0.79-1.37],0.797958385540729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1 [0.98-1.02],0.801525405689076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.01 [0.96-1.06],0.803761134608083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PALM2,Paralemmin-2,Inverse variance weighted,8,1.01 [0.94-1.09],0.808143660043128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LPL,Lipoprotein lipase,Inverse variance weighted,14,1.01 [0.92-1.11],0.81228306165362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOL1,Apolipoprotein L1,Inverse variance weighted,3,0.99 [0.92-1.07],0.816133962099366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.01 [0.93-1.1],0.817658427013073,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1 [0.97-1.03],0.818377920657268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.99 [0.9-1.08],0.819905414276717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLXNB2,Plexin-B2,Inverse variance weighted,27,1 [0.98-1.02],0.820621673435944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.01 [0.96-1.05],0.822034335079552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MBL2,Mannose-binding protein C,Inverse variance weighted,40,1 [0.97-1.03],0.823330938228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,0.97 [0.71-1.31],0.826220670017908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.97 [0.76-1.24],0.828422269447089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,5,0.99 [0.9-1.09],0.831285295001171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.01 [0.91-1.12],0.83265871242697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1 [0.97-1.04],0.833352002954107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.93 [0.49-1.79],0.834996587274138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,1.01 [0.93-1.1],0.837905157841888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,1.06 [0.61-1.83],0.838369131119262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.99 [0.91-1.08],0.840659915712314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,1.02 [0.87-1.19],0.845135709857114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KYNU,Kynureninase,Inverse variance weighted,8,1.01 [0.93-1.09],0.846433424369813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLK11,Kallikrein-11,Inverse variance weighted,6,1 [0.97-1.04],0.846763968173774,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.01 [0.9-1.14],0.849601648559777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,1.01 [0.87-1.18],0.856487341017939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.99 [0.91-1.08],0.857340673461308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS9,Galectin-9,Inverse variance weighted,26,1 [0.96-1.04],0.857644109283369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.97 [0.71-1.34],0.859959188658428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1 [0.97-1.03],0.863342068167423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCG3,Secretogranin-3,Inverse variance weighted,32,1 [0.96-1.04],0.863779820643417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.99 [0.87-1.13],0.864225731524943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.01 [0.86-1.19],0.866090468005308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.99 [0.9-1.1],0.868544805572506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1 [0.96-1.04],0.869268802615355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CDH1,Cadherin-1,Wald ratio,1,1.03 [0.69-1.54],0.872134084114139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.98 [0.73-1.32],0.876819055295279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,1 [0.97-1.03],0.877935345149087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSS,Cathepsin S,Inverse variance weighted,23,1 [0.96-1.04],0.883900895256336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,S100P,Protein S100-P,Inverse variance weighted,2,0.98 [0.76-1.27],0.886748096967915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DSC2,Desmocollin-2,Inverse variance weighted,9,1 [0.94-1.06],0.88860000612197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.01 [0.83-1.24],0.893766206276746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.96 [0.56-1.66],0.894419671684794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APCS,Serum amyloid P-component,Inverse variance weighted,4,1 [0.93-1.08],0.894466781855886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS1,Galectin-1,Inverse variance weighted,6,1 [0.93-1.06],0.897361411856124,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NECTIN2,Nectin-2,Inverse variance weighted,5,0.98 [0.76-1.27],0.897443748967136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CFH,Complement factor H,Inverse variance weighted,19,1 [0.94-1.05],0.898637200151167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.99 [0.87-1.13],0.899349628592829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD302,CD302 antigen,Inverse variance weighted,9,1 [0.94-1.07],0.899920485944719,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,1 [0.96-1.04],0.900988432016657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1 [0.96-1.04],0.908884626800998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1 [0.98-1.02],0.912208778913345,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.99 [0.84-1.17],0.912688592159063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.99 [0.88-1.12],0.913907563112293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AGRP,Agouti-related protein,Inverse variance weighted,3,0.98 [0.72-1.35],0.916322877695329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLK14,Kallikrein-14,Inverse variance weighted,15,1 [0.96-1.04],0.922591840418858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD209,CD209 antigen,Inverse variance weighted,15,1 [0.94-1.06],0.924732754264875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.99 [0.79-1.24],0.927501843003179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD276,CD276 antigen,Inverse variance weighted,20,1 [0.97-1.03],0.928422188599103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1 [0.95-1.05],0.93230588820897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.01 [0.84-1.21],0.933616501134019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1 [0.95-1.06],0.933734701726928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOA2,Apolipoprotein A-II,Wald ratio,1,1.01 [0.76-1.34],0.935961899598605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1 [0.91-1.1],0.938186214078467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1 [0.88-1.13],0.938646253007486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,0.99 [0.8-1.22],0.938828791705716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FAM3B,Protein FAM3B,Inverse variance weighted,18,1 [0.97-1.04],0.941513267916079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,1.01 [0.87-1.15],0.942786405929135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1 [0.96-1.04],0.947212318044287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1 [0.95-1.06],0.947681983850402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1 [0.94-1.06],0.948316231353067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1 [0.96-1.04],0.951281946596777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RBP2,Retinol-binding protein 2,Wald ratio,1,0.99 [0.73-1.35],0.954442431010615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1 [0.9-1.11],0.955414530556063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1 [0.84-1.17],0.955539005575681,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MDK,Midkine,Inverse variance weighted,4,1 [0.89-1.14],0.959222236487718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1 [0.88-1.13],0.960874771157389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,1 [0.93-1.07],0.969142028256545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1 [0.93-1.08],0.969516037995496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PRSS2,Trypsin-2,Inverse variance weighted,3,1 [0.81-1.22],0.97213326873412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1 [0.96-1.04],0.972737425469181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MVK,Mevalonate kinase,Inverse variance weighted,2,0.99 [0.61-1.62],0.972969499701284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1 [0.96-1.04],0.974102981534951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1 [0.93-1.08],0.974673276163742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CSTB,Cystatin-B,Inverse variance weighted,28,1 [0.96-1.05],0.974926545555813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1 [0.94-1.07],0.9758653140109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.95-1.06],0.975948233412513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS3,Galectin-3,Inverse variance weighted,25,1 [0.96-1.04],0.975955711429654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1 [0.92-1.09],0.977581952154772,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GUCA2A,Guanylin,Inverse variance weighted,9,1 [0.9-1.1],0.979412256998515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1 [0.88-1.13],0.981264859924007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1 [0.73-1.38],0.984258274924089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,INHBC,Inhibin beta C chain,Inverse variance weighted,29,1 [0.97-1.03],0.984928314323541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1 [0.94-1.07],0.985861454628983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1 [0.95-1.05],0.985939222938438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1 [0.96-1.04],0.987129614773513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,1 [0.63-1.59],0.992267820959763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1 [0.96-1.04],0.993048866666934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SEPTIN8,Septin-8,Inverse variance weighted,2,1 [0.87-1.14],0.993441348580567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1 [0.89-1.12],0.998964096479735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,5.59 [3.75-8.33],3.00893730642201e-17,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,4.44 [2.79-7.07],3.33628870873404e-10,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GSTA1,Glutathione S-transferase A1,Wald ratio,1,0.33 [0.21-0.51],1.48973720425363e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GRN,Progranulin,Inverse variance weighted,46,1.12 [1.07-1.17],2.11526537115565e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,0.68 [0.58-0.81],7.61031247321863e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,2.15 [1.51-3.06],2.07190152846694e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS4,Galectin-4,Inverse variance weighted,15,0.9 [0.85-0.95],7.24304244556987e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.4 [1.16-1.69],0.000349275209746199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.43 [1.16-1.75],0.000687660456081988,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.85 [0.77-0.93],0.000916049056050726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,20,1.16 [1.06-1.27],0.00158472956677127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,11,1.17 [1.06-1.29],0.0024511374690354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,0.47 [0.28-0.77],0.00287558089854233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CPE,Carboxypeptidase E,Inverse variance weighted,10,0.81 [0.7-0.94],0.00526037990696988,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1.06 [1.02-1.11],0.00656408663343653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.27 [1.06-1.52],0.00808206796932348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,2.19 [1.2-4.01],0.0108206046861834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPON1,Spondin-1,Inverse variance weighted,4,1.28 [1.06-1.55],0.0117805337955337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.8 [0.67-0.96],0.0140703179128725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.05 [1.01-1.1],0.0146139431540237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.84 [0.73-0.97],0.0146785475711855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EZR,Ezrin,Wald ratio,1,0.62 [0.42-0.92],0.0168829598771738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PPL,Periplakin,Inverse variance weighted,2,1.35 [1.06-1.72],0.0168843416921899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.2 [1.03-1.4],0.0171621638541781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MPO,Myeloperoxidase,Inverse variance weighted,17,1.07 [1.01-1.13],0.0188464743824265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.3 [1.04-1.63],0.0189973114789462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.17 [1.03-1.34],0.0197458984606638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.89 [0.81-0.98],0.0200600644769793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSB,Cathepsin B,Inverse variance weighted,28,0.91 [0.84-0.99],0.0251864839306246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.62 [0.4-0.95],0.0266948303470712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.71 [0.52-0.97],0.0291345525938063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.2 [1.02-1.41],0.029452663547931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.11 [1.01-1.21],0.0300376197946209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCN4,CCN family member 4,Inverse variance weighted,29,1.05 [1-1.09],0.0310880893239946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.29 [1.02-1.63],0.0312739897951467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.72 [0.54-0.98],0.0346011742567555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOL1,Apolipoprotein L1,Inverse variance weighted,46,0.96 [0.92-1],0.0356309734817348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.29 [1.02-1.65],0.0356965392420584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.96 [0.93-1],0.0360917523623132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL6,Interleukin-6,Inverse variance weighted,6,0.92 [0.85-0.99],0.0368468664550869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.95 [1.04-3.65],0.0378102194070013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BCAN,Brevican core protein,Inverse variance weighted,12,1.17 [1.01-1.35],0.0388199717320848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.44 [1.02-2.04],0.0400963897583589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.08 [1-1.16],0.0401458939941618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLG,Plasminogen,Inverse variance weighted,6,1.35 [1.01-1.8],0.0408451354706175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.04 [1-1.09],0.0409426633974195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.41 [1.01-1.96],0.0414479095466501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KYNU,Kynureninase,Inverse variance weighted,3,1.79 [1.02-3.13],0.0422322756909734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD83,CD83 antigen,Inverse variance weighted,14,0.88 [0.78-1],0.0429415672901685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.09 [1-1.18],0.044177124150419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.85 [1.01-3.38],0.0453756305936736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PGA4,Pepsin A-4,Inverse variance weighted,7,0.84 [0.71-1],0.0471995577885217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.9 [0.81-1],0.0484170949700629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.9 [0.82-1],0.049724752758221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.11 [1-1.23],0.0513847728696998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,XG,Glycoprotein Xg,Inverse variance weighted,2,0.73 [0.54-1.01],0.0553094190878459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.9 [0.8-1],0.0571180771221124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP7,Matrilysin,Wald ratio,1,0.85 [0.72-1.01],0.0609433770876913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.96 [0.92-1],0.0620805102666417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSL,Cathepsin L1,Inverse variance weighted,29,1.07 [1-1.15],0.0629146963123279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.14 [0.99-1.3],0.0637990165093421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LPL,Lipoprotein lipase,Inverse variance weighted,8,0.63 [0.39-1.03],0.0641945417489054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.3 [0.98-1.72],0.0691905648606294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.46 [0.97-2.21],0.0715866235750387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.09 [0.99-1.2],0.07485706154572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.61 [0.35-1.06],0.0777211180140999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NRP2,Neuropilin-2,Inverse variance weighted,14,1.14 [0.99-1.31],0.0783939008585861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.12 [0.99-1.27],0.0805162512977304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.17 [0.98-1.39],0.0815919609021477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.88 [0.77-1.02],0.0818159001150642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.29 [0.97-1.72],0.0821476907276741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.12 [0.99-1.26],0.0837760223160009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,1.15 [0.98-1.35],0.0879922194285934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.96 [0.92-1.01],0.088246736235186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.16 [0.98-1.36],0.0896591457200928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MFGE8,Lactadherin,Inverse variance weighted,15,1.27 [0.96-1.68],0.0897166581951058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.48 [0.94-2.33],0.0905046240515219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AGRP,Agouti-related protein,Inverse variance weighted,16,1.18 [0.97-1.44],0.0951153430875364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.13 [0.98-1.31],0.0963665844446799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.05 [0.99-1.11],0.0969359714285436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.9 [0.8-1.02],0.100116053040171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,C7,Complement component C7,Inverse variance weighted,26,1.03 [0.99-1.07],0.101556029851249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.24 [0.96-1.6],0.103457025581874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.13 [0.97-1.32],0.103974294834701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS3,Galectin-3,Inverse variance weighted,15,1.12 [0.98-1.28],0.105675921539234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.86 [0.72-1.03],0.105804234513957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,0.9 [0.79-1.02],0.107008309345261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.02 [1-1.05],0.108468064718541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.14 [0.97-1.33],0.108737964732435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1.03 [0.99-1.07],0.109969456844675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCN3,CCN family member 3,Inverse variance weighted,17,1.05 [0.99-1.11],0.110722753107534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VWC2,Brorin,Inverse variance weighted,12,1.14 [0.97-1.35],0.111102780229002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.09 [0.98-1.23],0.118613250727131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.06 [0.99-1.13],0.119477536638099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.12 [0.97-1.3],0.122483025507235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.68 [0.41-1.11],0.123988407485257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANG,Angiogenin,Inverse variance weighted,8,1.23 [0.94-1.6],0.126019940448558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.22 [0.94-1.57],0.127614351724308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.88 [0.74-1.04],0.127626029969307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.14 [0.96-1.34],0.129793535150095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MENT,Protein MENT,Inverse variance weighted,28,1.09 [0.97-1.22],0.131453762057069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.32 [0.92-1.9],0.132098867940459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLB,Beta-klotho,Inverse variance weighted,23,1.08 [0.98-1.19],0.132978003206849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,0.91 [0.81-1.03],0.133218887602256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,0.91 [0.81-1.03],0.134287152437778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.14 [0.96-1.35],0.134638913421706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.18 [0.95-1.46],0.135189630103544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC3B,Tetranectin,Inverse variance weighted,2,1.29 [0.92-1.81],0.139392672028108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1.06 [0.98-1.16],0.140361277665485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GCG,Pro-glucagon,Inverse variance weighted,2,1.26 [0.93-1.71],0.140818829513748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.93 [0.84-1.02],0.141160878862305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.91 [0.8-1.03],0.144875789865055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.27 [0.92-1.76],0.153488294923932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOE,Apolipoprotein E,Inverse variance weighted,6,1.3 [0.91-1.86],0.155549505304419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.91 [0.79-1.04],0.157467728695448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOD,Apolipoprotein D,Inverse variance weighted,9,0.65 [0.35-1.18],0.157535476782915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.12 [0.96-1.31],0.159339350289438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FBLN2,Fibulin-2,Inverse variance weighted,6,1.23 [0.92-1.63],0.159675590765966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.16 [0.94-1.43],0.16083317810142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.08 [0.97-1.2],0.163655961217616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EGLN1,Egl nine homolog 1,Wald ratio,1,0.73 [0.47-1.14],0.165003709668127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.6 [0.82-3.14],0.170431378866193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PRSS2,Trypsin-2,Inverse variance weighted,17,0.92 [0.81-1.04],0.171090104745575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.94 [0.87-1.03],0.172347915220198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,0.93 [0.84-1.03],0.17261881796758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.13 [0.95-1.34],0.173122320830962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.09 [0.96-1.23],0.173718370648755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,0.96 [0.9-1.02],0.173892033912767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.29 [0.89-1.86],0.174257269668267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL11,Eotaxin,Inverse variance weighted,11,1.05 [0.98-1.13],0.175891958884775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.26 [0.9-1.77],0.176113741284734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.38 [0.86-2.21],0.178265107744539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BCHE,Cholinesterase,Inverse variance weighted,38,1.04 [0.98-1.09],0.178843462256568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.93 [0.84-1.03],0.180481603372924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.31 [0.88-1.94],0.181104963180468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.11 [0.95-1.3],0.183268572882291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.94 [0.85-1.03],0.187362551243786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAYN,Layilin,Inverse variance weighted,3,1.19 [0.92-1.54],0.187538120890134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.92 [0.82-1.04],0.188520654187308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.94 [0.86-1.03],0.19006753561979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.06 [0.97-1.14],0.190293425416939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.91 [0.79-1.05],0.192979996827323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FURIN,Furin,Inverse variance weighted,3,0.84 [0.64-1.09],0.194523758794665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,11,1.25 [0.89-1.74],0.194773247116373,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.28 [0.88-1.84],0.195466750253186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.91 [0.79-1.05],0.195908419522098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.03 [0.98-1.08],0.196031647659889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.97 [0.92-1.02],0.200751161866691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.06 [0.97-1.17],0.201385827178008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.81 [0.59-1.12],0.20199791923042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.17 [0.92-1.48],0.202038984095992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD27,CD27 antigen,Inverse variance weighted,9,0.86 [0.67-1.09],0.203246422782493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.84 [0.65-1.1],0.20623957942243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.16 [0.92-1.46],0.207482430789694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.88 [0.73-1.07],0.208655930467462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.88 [0.73-1.07],0.210605896711749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.38 [0.83-2.3],0.215953285435078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.13 [0.93-1.37],0.217183924874241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.27 [0.87-1.86],0.218888127065335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,0.99 [0.96-1.01],0.219234510128417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.09 [0.95-1.26],0.220400666137217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NFASC,Neurofascin,Inverse variance weighted,6,0.75 [0.47-1.19],0.222165869394798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.82 [0.6-1.12],0.222461384755508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPO,Erythropoietin,Inverse variance weighted,11,0.93 [0.84-1.04],0.222489834099507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.16 [0.91-1.46],0.225173105025091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,UMOD,Uromodulin,Inverse variance weighted,34,0.95 [0.87-1.03],0.226077804431465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.12 [0.93-1.33],0.230525686628962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MSLN,Mesothelin,Inverse variance weighted,11,1.08 [0.95-1.23],0.235146011145444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.88 [0.7-1.09],0.236294577475122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.06 [0.96-1.16],0.242028618211567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.09 [0.94-1.27],0.245200668456511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.04 [0.98-1.1],0.247504892835216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.07 [0.95-1.19],0.249588760411008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLK14,Kallikrein-14,Inverse variance weighted,15,1.07 [0.95-1.21],0.250032227320099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.02 [0.99-1.04],0.253255095320387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.85 [0.65-1.12],0.259410083292122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.93 [0.82-1.06],0.263879136632195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1.02 [0.98-1.06],0.264114711868514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.04 [0.97-1.13],0.265154422555431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NECTIN4,Nectin-4,Inverse variance weighted,4,1.18 [0.88-1.57],0.266686255659259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AREG,Amphiregulin,Inverse variance weighted,5,1.12 [0.92-1.37],0.267894451660171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.11 [0.92-1.34],0.270351426658986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.91 [0.78-1.07],0.270532820839648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.93 [0.81-1.06],0.270986624542131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.98-1.06],0.271417788901782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.14 [0.9-1.46],0.277351802400291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HEPACAM2,HEPACAM family member 2,Inverse variance weighted,69,0.98 [0.95-1.01],0.277531246449223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.09 [0.94-1.26],0.278348390229985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.04 [0.97-1.12],0.278524256476158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MME,Neprilysin,Inverse variance weighted,46,1.03 [0.98-1.09],0.278533971906353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLK11,Kallikrein-11,Inverse variance weighted,13,1.05 [0.96-1.16],0.282950173511439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.14 [0.89-1.46],0.283545877054039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.07 [0.94-1.22],0.284418774639857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.13 [0.9-1.41],0.286755477913053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.11 [0.91-1.36],0.287184406494962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,11,0.94 [0.84-1.05],0.289039904844634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.88 [0.69-1.12],0.2899003325044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,L1CAM,Neural cell adhesion molecule L1,Inverse variance weighted,21,1.08 [0.94-1.23],0.290906128700638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.96 [0.88-1.04],0.290962653449411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.95 [0.87-1.04],0.292923890830663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.03 [0.98-1.09],0.29403420801774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHGA,Chromogranin-A,Inverse variance weighted,5,1.09 [0.93-1.29],0.295351634560443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.05 [0.96-1.15],0.296564169355518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.03 [0.97-1.09],0.303285760806553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PYY,Peptide YY,Inverse variance weighted,16,1.04 [0.97-1.11],0.303285796573593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.1 [0.92-1.3],0.305327370326657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.07 [0.94-1.23],0.306354049504186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.96 [0.88-1.04],0.309800182537085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NRP1,Neuropilin-1,Inverse variance weighted,14,0.92 [0.78-1.08],0.309818894844209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.97 [0.92-1.03],0.310425591745881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.04 [0.97-1.12],0.3106785651901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,1.03 [0.97-1.09],0.31134771394229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSO,Cathepsin O,Inverse variance weighted,19,0.89 [0.7-1.12],0.31559421792132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.94 [0.85-1.06],0.317198778669101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.05 [0.96-1.14],0.31813495983423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CST3,Cystatin-C,Inverse variance weighted,3,1.14 [0.88-1.46],0.318976427318793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.08 [0.93-1.25],0.320028585635132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.04 [0.96-1.13],0.322875512651102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CAPG,Macrophage-capping protein,Wald ratio,1,1.19 [0.84-1.68],0.323447840701862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.93 [0.8-1.08],0.326404781778885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PRSS8,Prostasin,Inverse variance weighted,14,0.94 [0.82-1.07],0.327701604248154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.9 [0.72-1.12],0.328280933195162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.91 [0.76-1.1],0.331537439656346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.96 [0.88-1.04],0.336800829761013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RTBDN,Retbindin,Inverse variance weighted,2,1.18 [0.84-1.66],0.338226118735392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CFI,Complement factor I,Wald ratio,1,0.76 [0.43-1.34],0.341010467025266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.17 [0.85-1.61],0.343813883974851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DCN,Decorin,Inverse variance weighted,2,0.7 [0.33-1.48],0.344878921807517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.01 [0.99-1.04],0.349388804724228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.11 [0.89-1.37],0.349551540410303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,1.07 [0.93-1.23],0.350127362860026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.9 [0.71-1.13],0.352518298622686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTN,Pleiotrophin,Inverse variance weighted,3,0.9 [0.72-1.13],0.352670045519932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.12 [0.88-1.44],0.352759126064783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.12 [0.88-1.43],0.353192014600588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.14 [0.87-1.5],0.353864924257391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.93 [0.8-1.08],0.356281876976421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.96 [0.89-1.04],0.36424533949352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,0.9 [0.72-1.13],0.370516133052292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.09 [0.9-1.32],0.375992885698763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.83 [0.56-1.25],0.377776139992256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.9 [0.7-1.14],0.379391504849606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TCOF1,Treacle protein,Wald ratio,1,1.21 [0.78-1.88],0.385061126737927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.11 [0.88-1.4],0.386110112179886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,POF1B,Protein POF1B,Inverse variance weighted,4,0.93 [0.79-1.1],0.386870457533864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.04 [0.95-1.13],0.389773193661276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.73 [0.36-1.5],0.390611336863804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.91 [0.72-1.13],0.391757473199609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.88 [0.66-1.17],0.391956409422781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MDK,Midkine,Inverse variance weighted,14,0.96 [0.87-1.06],0.392407359344522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.08 [0.9-1.3],0.395756883278466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.94 [0.82-1.08],0.399847946708488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CREG1,Protein CREG1,Inverse variance weighted,20,0.97 [0.9-1.04],0.402116023747224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.98 [0.94-1.03],0.402854006319111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CALB1,Calbindin,Inverse variance weighted,9,0.95 [0.85-1.07],0.402947488906699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.98 [0.92-1.03],0.40599443531462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.93 [0.8-1.1],0.407953390834528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.03 [0.96-1.1],0.408701070299119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RSPO3,R-spondin-3,Inverse variance weighted,5,0.87 [0.63-1.21],0.40944284182879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.98 [0.95-1.02],0.409544544369578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ELN,Elastin,Inverse variance weighted,10,1.15 [0.83-1.59],0.410884702804449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GAST,Gastrin,Inverse variance weighted,9,0.94 [0.82-1.08],0.410970479376441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.07 [0.92-1.24],0.411708687534094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.06 [0.93-1.2],0.413319765369346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.18 [0.8-1.74],0.416198131547644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,0.84 [0.56-1.27],0.416527861428322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,18,1.02 [0.97-1.06],0.417209655661262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.88 [0.64-1.2],0.417953499958787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.9 [0.7-1.16],0.4206794015257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSF,Cathepsin F,Inverse variance weighted,27,1.04 [0.95-1.14],0.421193999397799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL10,Interleukin-10,Inverse variance weighted,4,1.03 [0.95-1.12],0.423879735835641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.22 [0.75-1.99],0.428932810475779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AMBP,Protein AMBP,Inverse variance weighted,5,1.13 [0.84-1.53],0.429982412730698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.41 [0.6-3.32],0.430839741336253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.07 [0.9-1.28],0.433463659064758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,26,0.97 [0.89-1.05],0.433724921534217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.07 [0.9-1.27],0.435866381933188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1.03 [0.95-1.12],0.437790639783197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.98 [0.92-1.03],0.437821949034852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.15 [0.8-1.66],0.438245853913657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AGRN,Agrin,Inverse variance weighted,14,1.06 [0.91-1.23],0.441687643489078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.04 [0.93-1.17],0.44616095259976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.27 [0.68-2.35],0.451690028666971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OGN,Mimecan,Inverse variance weighted,37,1.02 [0.97-1.06],0.451904716805893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.93 [0.78-1.12],0.45288335959259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD99,CD99 antigen,Inverse variance weighted,4,0.9 [0.67-1.19],0.452958739327486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,C3,Complement C3,Inverse variance weighted,2,1.07 [0.89-1.29],0.454081765814617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.1 [0.85-1.43],0.454467952285473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,6,1.16 [0.79-1.7],0.454734703299457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPP1,Osteopontin,Inverse variance weighted,13,0.94 [0.79-1.11],0.456004794918389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.07 [0.9-1.26],0.458979165809355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.13 [0.82-1.54],0.461623924755073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.09 [0.87-1.35],0.464307706933333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.09 [0.87-1.35],0.466512805299701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.06 [0.91-1.24],0.469652804963428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.01 [0.98-1.05],0.471321921662796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CFP,Properdin,Inverse variance weighted,17,1.02 [0.96-1.09],0.471795224912587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.93 [0.75-1.14],0.477796699485336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DPT,Dermatopontin,Inverse variance weighted,4,1.09 [0.86-1.38],0.479644409268831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,0.96 [0.87-1.07],0.480359050219713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.74 [0.32-1.7],0.481893453890202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,1.13 [0.8-1.58],0.484353550492165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.97 [0.91-1.05],0.487399630176512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TMPRSS15,Enteropeptidase,Inverse variance weighted,11,1.06 [0.9-1.24],0.490079814140617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.93 [0.77-1.14],0.494582699846868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,0.85 [0.52-1.37],0.496103835114244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.2 [0.71-2],0.497355201223138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.98 [0.93-1.04],0.500844878810745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPON2,Spondin-2,Inverse variance weighted,3,0.88 [0.62-1.27],0.5009985720284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.07 [0.87-1.32],0.50198540655311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.05 [0.91-1.21],0.503339883274155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.05 [0.91-1.22],0.503482097891074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.97 [0.9-1.06],0.50624115514739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.17 [0.74-1.85],0.508196145105243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.98 [0.93-1.04],0.5088052831626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.05 [0.91-1.2],0.510930831053676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.02 [0.97-1.07],0.51199563810407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.07 [0.87-1.32],0.512669455346395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,1.1 [0.82-1.47],0.515059658829603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.98 [0.94-1.03],0.516432424910182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.96 [0.85-1.09],0.518960596350325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,0.92 [0.72-1.18],0.520692128768477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.93 [0.74-1.17],0.521416453037458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.87 [0.57-1.32],0.521746633757835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.05 [0.91-1.22],0.52202920634218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REN,Renin,Inverse variance weighted,8,0.94 [0.78-1.13],0.527177755998997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.95 [0.82-1.11],0.52838896844525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LMNB2,Lamin-B2,Inverse variance weighted,8,1.06 [0.88-1.27],0.53107790447791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PENK,Proenkephalin-A,Inverse variance weighted,15,1.03 [0.95-1.11],0.53374937778953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,XCL1,Lymphotactin,Inverse variance weighted,15,0.96 [0.83-1.1],0.53621378208482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1.02 [0.95-1.1],0.537385666081577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.06 [0.88-1.29],0.539659032209932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCG3,Secretogranin-3,Inverse variance weighted,16,1.04 [0.92-1.16],0.54004103735251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.94 [0.77-1.15],0.540235510215362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,59,1.01 [0.98-1.04],0.540303399636459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL19,Interleukin-19,Inverse variance weighted,10,1.03 [0.93-1.14],0.540809729301239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.96 [0.86-1.08],0.541241715981499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.02 [0.95-1.1],0.542120026445722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.93 [0.72-1.19],0.544033105126032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.41 [0.46-4.36],0.545923391193515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CFD,Complement factor D,Wald ratio,1,0.89 [0.6-1.31],0.548908103593253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.02 [0.96-1.09],0.551091865537908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GUCA2A,Guanylin,Inverse variance weighted,7,0.95 [0.8-1.13],0.552488333304556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,0.98 [0.91-1.05],0.55467697290198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.21 [0.64-2.28],0.555493234562094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.91 [0.66-1.25],0.562423523519291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.89 [0.61-1.31],0.563165453399726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.21 [0.63-2.34],0.565304044355223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.09 [0.81-1.46],0.569835070717196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.03 [0.93-1.13],0.578362551605827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.08 [0.82-1.42],0.57917852398071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.04 [0.91-1.18],0.579414294585669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,10,1.04 [0.91-1.19],0.580120428499806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CNTN5,Contactin-5,Inverse variance weighted,22,0.98 [0.9-1.06],0.586881604893772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.98 [0.9-1.06],0.588101794354635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD209,CD209 antigen,Inverse variance weighted,34,0.99 [0.95-1.03],0.590819753552714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.98 [0.89-1.07],0.591558276581505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADA,Adenosine deaminase,Inverse variance weighted,22,0.99 [0.96-1.02],0.592519149757292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.97 [0.86-1.09],0.594586951122985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TF,Serotransferrin,Inverse variance weighted,6,0.88 [0.56-1.4],0.594888026171981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.93 [0.73-1.2],0.596656855533716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.98 [0.91-1.06],0.597037598970614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.94 [0.75-1.18],0.597837837339859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.99 [0.96-1.02],0.598703323102166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.9 [0.6-1.35],0.601145463801586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.95 [0.78-1.15],0.601263794234616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.98 [0.91-1.06],0.60233572200134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,1.03 [0.91-1.17],0.602485611016804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,1.02 [0.94-1.12],0.603105621987823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,1.12 [0.73-1.72],0.603252684169876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.96 [0.83-1.12],0.608480061780545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.01 [0.97-1.05],0.609205753381902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.05 [0.87-1.26],0.615438100758384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.93 [0.7-1.24],0.618729900260027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.98 [0.9-1.06],0.619165275133932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.96 [0.83-1.11],0.620854180806207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,UPB1,Beta-ureidopropionase,Wald ratio,1,0.76 [0.26-2.25],0.621007819374727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.93 [0.71-1.23],0.623669219088023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.07 [0.81-1.42],0.624411562812831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,0.98 [0.9-1.06],0.625742913107098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EGFLAM,Pikachurin,Wald ratio,1,1.16 [0.63-2.12],0.628952143332924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.09 [0.76-1.58],0.631938987807888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.12 [0.7-1.79],0.633936180556393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.04 [0.89-1.21],0.63397596960285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.28 [0.47-3.49],0.634494372088952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.04 [0.88-1.23],0.637918529157384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.9 [0.57-1.42],0.639002415934043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCN5,CCN family member 5,Inverse variance weighted,12,1.02 [0.95-1.08],0.639804475764811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.96 [0.83-1.13],0.643976149644736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.96 [0.79-1.16],0.648095757537121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HJV,Hemojuvelin,Inverse variance weighted,2,0.76 [0.23-2.47],0.648990469382063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NECTIN2,Nectin-2,Inverse variance weighted,3,1.07 [0.79-1.45],0.653634066888611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.87 [0.47-1.61],0.663358505224566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACAN,Aggrecan core protein,Inverse variance weighted,30,1.02 [0.93-1.13],0.664109255654002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.04 [0.88-1.23],0.665014085484761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.06 [0.81-1.38],0.665301080174059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.94 [0.7-1.25],0.6669147223823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.01 [0.97-1.06],0.668432215047336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SERPINB8,Serpin B8,Inverse variance weighted,29,1 [0.97-1.02],0.669600224761077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.59 [0.05-6.82],0.66987182221033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,8,1.02 [0.93-1.12],0.671063494092055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.98 [0.9-1.07],0.676580736528486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.03 [0.9-1.17],0.678173891379726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PGF,Placenta growth factor,Inverse variance weighted,5,0.95 [0.76-1.2],0.678243219145347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,INHBC,Inhibin beta C chain,Inverse variance weighted,12,0.98 [0.89-1.08],0.680914193544931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP10,Stromelysin-2,Wald ratio,1,0.91 [0.57-1.45],0.68405304792358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.98 [0.9-1.08],0.690407207926242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CALCA,Calcitonin,Inverse variance weighted,13,1.03 [0.9-1.16],0.690585814404674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.09 [0.7-1.7],0.699260254916235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSD,Cathepsin D,Inverse variance weighted,7,1.05 [0.83-1.32],0.700499790619342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,0.96 [0.8-1.17],0.703772108820868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.04 [0.84-1.3],0.708939328863515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.95 [0.71-1.27],0.711266012995892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.93 [0.65-1.34],0.711484756260269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PTP4A3,Protein tyrosine phosphatase type IVA 3,Inverse variance weighted,6,0.99 [0.91-1.06],0.712471959220252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.01 [0.95-1.08],0.71254574776852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCG2,Secretogranin-2,Inverse variance weighted,2,1.11 [0.63-1.98],0.713853059018645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.99 [0.93-1.05],0.714895173772082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLK4,Kallikrein-4,Inverse variance weighted,5,0.92 [0.57-1.47],0.715465056042358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.04 [0.83-1.31],0.716643995209711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.98 [0.9-1.08],0.716976477140129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.99 [0.91-1.06],0.718982381423217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.96 [0.76-1.21],0.719832446107625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.09 [0.68-1.73],0.722438199079246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.79 [0.22-2.84],0.722489382471904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.02 [0.9-1.17],0.722902520197897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,0.99 [0.91-1.07],0.724518498195162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACY1,Aminoacylase-1,Inverse variance weighted,6,0.98 [0.86-1.11],0.726662723753675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LEP,Leptin,Inverse variance weighted,4,1.16 [0.49-2.74],0.72863641104059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.97 [0.8-1.17],0.730019035599243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.95 [0.7-1.28],0.730145783563815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MB,Myoglobin,Inverse variance weighted,9,0.97 [0.83-1.14],0.732849459450345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.97 [0.81-1.16],0.734789687870217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD276,CD276 antigen,Inverse variance weighted,24,0.99 [0.93-1.06],0.736575605594296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.03 [0.85-1.26],0.737158599223972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS9,Galectin-9,Inverse variance weighted,36,1.01 [0.97-1.05],0.737852407891762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP6,Gastrotropin,Inverse variance weighted,4,0.97 [0.78-1.19],0.739631307412547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PVR,Poliovirus receptor,Inverse variance weighted,3,1.1 [0.63-1.91],0.740410951776293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SDC1,Syndecan-1,Inverse variance weighted,12,1.02 [0.89-1.18],0.741351749074203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COLEC12,Collectin-12,Inverse variance weighted,3,1.11 [0.6-2.04],0.743181138438131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.05 [0.79-1.39],0.747574921611091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.98-1.03],0.747882904713839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OSM,Oncostatin-M,Inverse variance weighted,6,1.02 [0.91-1.14],0.750959249278378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.04 [0.8-1.37],0.751740329609682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.97 [0.8-1.17],0.753655636814801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,14,1.02 [0.9-1.15],0.758883319889376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.01 [0.93-1.11],0.764499198293113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,1.06 [0.71-1.6],0.76488440326576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.98 [0.89-1.09],0.767819762256359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.93 [0.59-1.47],0.769596067287519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.95 [0.69-1.31],0.772280146880072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.01 [0.92-1.11],0.774077111922525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,F9,Coagulation factor IX,Inverse variance weighted,3,1.06 [0.72-1.54],0.778336412490364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.99 [0.9-1.08],0.781246142328246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.97 [0.81-1.17],0.788958598687766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,1.06 [0.68-1.65],0.789229660595106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.03 [0.83-1.28],0.790035992932416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,1.02 [0.9-1.14],0.792818597739186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNN,Tenascin-N,Inverse variance weighted,41,1.01 [0.97-1.04],0.793106017154836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PALM2,Paralemmin-2,Inverse variance weighted,9,1.01 [0.94-1.09],0.794023036797925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.98 [0.82-1.16],0.799385438424184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CFC1,Cryptic protein,Inverse variance weighted,11,0.99 [0.88-1.1],0.801898033911877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.03 [0.81-1.31],0.802910987992627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.03 [0.79-1.35],0.803866231182664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.97 [0.76-1.23],0.804067844498103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.01 [0.92-1.11],0.805222317296036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,3,1.04 [0.77-1.39],0.8089972526095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.99 [0.87-1.11],0.811339871537451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.98 [0.82-1.17],0.812187391037591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PKD1,Polycystin-1,Inverse variance weighted,12,0.97 [0.78-1.21],0.81586391248714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,18,0.99 [0.88-1.11],0.817226878033269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.98 [0.82-1.17],0.818032628557623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.03 [0.81-1.31],0.81818144933958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HEPH,Hephaestin,Inverse variance weighted,6,0.98 [0.86-1.13],0.818560248877561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.99 [0.9-1.08],0.819905414276717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.02 [0.84-1.24],0.82545086319263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,WNT9A,Protein Wnt-9a,Wald ratio,1,0.94 [0.56-1.59],0.826076166180766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,0.99 [0.95-1.04],0.828716501416432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.98 [0.8-1.2],0.830207764114394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.99 [0.87-1.12],0.833912636945354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.03 [0.78-1.36],0.845372637006145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,1.01 [0.89-1.15],0.849440469190842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.03 [0.76-1.39],0.849944093729529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.97 [0.72-1.32],0.850867267082378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1 [0.97-1.03],0.852424790244342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.03 [0.72-1.48],0.852535815969611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.99 [0.9-1.09],0.854875874222182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.09 [0.43-2.78],0.855104221005438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.95 [0.53-1.69],0.856122139299593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.98 [0.76-1.26],0.857222525672084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.01 [0.93-1.09],0.857499406116139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,1.01 [0.87-1.18],0.858557251018541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.96 [0.58-1.57],0.858652831837158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MVK,Mevalonate kinase,Wald ratio,1,0.92 [0.36-2.35],0.868448264639958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PSAP,Prosaposin,Inverse variance weighted,13,0.99 [0.92-1.07],0.870670041271511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.02 [0.82-1.26],0.874891337634201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.01 [0.91-1.12],0.875087781652987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.03 [0.72-1.46],0.878246611565728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,24,1 [0.95-1.06],0.883078351679663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,0.95 [0.51-1.79],0.88404105308026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.99 [0.81-1.19],0.885648591217679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.01 [0.84-1.23],0.886180799683794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,0.99 [0.87-1.13],0.886452329627574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.01 [0.85-1.21],0.887909467414939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,1.03 [0.69-1.52],0.889181069583277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SELL,L-selectin,Inverse variance weighted,11,1.01 [0.87-1.17],0.890557894245579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD302,CD302 antigen,Inverse variance weighted,11,1.01 [0.89-1.14],0.893051509350207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,0.99 [0.89-1.11],0.897748907966806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.98 [0.71-1.35],0.89800940502413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.98 [0.72-1.34],0.900069115660331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1 [0.97-1.04],0.901722536321708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,S100P,Protein S100-P,Inverse variance weighted,4,1.02 [0.76-1.36],0.905015606248539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MUC13,Mucin-13,Inverse variance weighted,3,0.98 [0.69-1.39],0.905680885226544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MBL2,Mannose-binding protein C,Inverse variance weighted,42,1 [0.96-1.03],0.906816245383307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1 [0.93-1.08],0.907614299147547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,OCLN,Occludin,Inverse variance weighted,2,1.02 [0.78-1.32],0.910465318350315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.99 [0.83-1.18],0.912239359552825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1 [0.93-1.07],0.912544180935401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.01 [0.89-1.14],0.915532070485645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.99 [0.86-1.15],0.915918450389178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.99 [0.76-1.27],0.91747823107291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CDH1,Cadherin-1,Inverse variance weighted,16,1 [0.92-1.08],0.91983957867671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHGB,Secretogranin-1,Inverse variance weighted,7,0.99 [0.83-1.18],0.921711862749127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,6,1 [0.9-1.1],0.926244201449891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.01 [0.85-1.19],0.927408040126066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.99 [0.81-1.21],0.929330981373693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.99 [0.82-1.2],0.929369741313302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.99 [0.88-1.12],0.930896470740436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CDH2,Cadherin-2,Inverse variance weighted,21,0.99 [0.81-1.21],0.931375551445788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CSTB,Cystatin-B,Inverse variance weighted,23,1 [0.95-1.05],0.931504413860866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PALM,Paralemmin-1,Inverse variance weighted,4,0.99 [0.83-1.19],0.932330560618205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1 [0.9-1.12],0.933537663089185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TFF3,Trefoil factor 3,Inverse variance weighted,10,1 [0.91-1.1],0.937168331658823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SEPTIN8,Septin-8,Inverse variance weighted,4,0.99 [0.74-1.32],0.93737285847236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,0.99 [0.75-1.31],0.939483204306334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1 [0.97-1.03],0.942236445880883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.99 [0.74-1.33],0.942579292532232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,1 [0.89-1.13],0.943547177298185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DSC2,Desmocollin-2,Inverse variance weighted,16,1 [0.95-1.06],0.94380961723431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1 [0.88-1.12],0.944464141554023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,37,1 [0.92-1.08],0.945321724716949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.01 [0.78-1.31],0.945329458514738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.98 [0.53-1.83],0.951521860370789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1 [0.91-1.11],0.954671373860679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CFH,Complement factor H,Inverse variance weighted,7,1 [0.85-1.18],0.960643258655124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CTSS,Cathepsin S,Inverse variance weighted,7,1 [0.88-1.15],0.961304194184309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.99 [0.78-1.26],0.961875264329541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,LPA,Apolipoprotein(a),Inverse variance weighted,2,1 [0.82-1.23],0.962575529595407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,35,1 [0.95-1.05],0.964503056582938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,1.01 [0.76-1.34],0.965954953317841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,IL17C,Interleukin-17C,Inverse variance weighted,5,1.01 [0.74-1.37],0.967760656944459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.99 [0.77-1.29],0.969216232947605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,NTF3,Neurotrophin-3,Inverse variance weighted,11,1 [0.82-1.22],0.972751486120347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1 [0.79-1.27],0.981366042039383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1 [0.72-1.37],0.984214481909445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1 [0.85-1.17],0.986141137558793,trans
